Heritage Insurance Holdings (NASDAQ:HRTG) said in a regulatory filing that Chief Executive Officer Ernie J. Garateix sold 8,334 shares of the company's common stock on March 20, 2026. According to the Form 4 filing with the Securities and Exchange Commission, the sales averaged $25.3875 per share, producing a total transaction value of $211,579. The executed sales were priced between $25.12 and $25.715 per share.
Following the disposition, Garateix still directly owns 1,069,289 shares of Heritage Insurance Holdings. The filing notes the trades were made under a pre-arranged Rule 10b5-1 trading plan that the executive adopted on June 13, 2025.
The insider sale took place against a backdrop of recent stock volatility - Heritage Insurance shares have declined nearly 10% over the prior week while remaining up 89% over the last year. The filing does not attach any additional commentary from the executive about the transaction beyond the reference to the 10b5-1 plan.
Company performance and analyst activity
Heritage Insurance reported fourth-quarter results that outpaced analyst expectations, a performance attributed in the filing materials to improved underwriting outcomes and lower catastrophe losses. Following the quarterly report, Truist Securities raised its price target for Heritage Insurance to $39 from $37 while keeping a Buy rating. Truist also increased its 2026 earnings per share estimate for the company to $5.00 from $4.50 and provided a 2027 EPS forecast of $5.55.
Other broker commentary cited in filings shows Piper Sandler reaffirming an Overweight rating on Heritage Insurance ahead of the company's fourth-quarter 2025 earnings report and naming the stock as a weekly focus idea. Meanwhile, Citizens maintained a Market Perform rating and highlighted that the accumulation of excess capital should support further growth.
One balance-sheet metric noted in recent commentary is that Heritage Insurance's net written premium-to-equity ratio has fallen below 2.0x, a level described as indicative of excess capital within the business. Taken together, these developments were described as reflecting ongoing positive momentum for the company.
What is not addressed
The Form 4 and the company commentary do not provide additional detail about the CEO's personal rationale beyond the existence of the trading plan, nor do they offer guidance that ties the insider sale directly to the analyst actions or the recent share-price movement. The filings also do not disclose future planned trades under the 10b5-1 arrangement.